On Monday, Halozyme Therapeutics, Inc. (HALO) stock saw a modest uptick, ending the day at $53.95 which represents a slight increase of $0.95 or 1.79% from the prior close of $53. The stock opened at ...
Unreal Engine 5 has been revolutionising game design, and we've just seen a new, and unexpected example. 343 Industries, now renamed as Halo Studios, has announced that it's moving from its ...